3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia, Myeloid, Acute
6
Myelodysplastic Syndromes
4
Lymphoma
3
Leukemia
3
Primary Myelofibrosis
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Graft vs Host Disease
2
Burkitt Lymphoma
2
Blast Crisis
2
Anemia, Refractory, with Excess of Blasts
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Thalassemia
1
Sezary Syndrome
1
Recurrence
1
Pseudomyxoma Peritonei
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neoplasms, Plasma Cell
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
avelumab
1
aldesleukin
1
Nivolumab
1
Cyclophosphamide
1
Axitinib
1
Antineoplastic Protocols
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
Tacrolimus
×
30 days
×
Clear all
No trials found.